TOBI is the only FDA-approved inhaled antibiotic that has helped people with CF fight Pseudomonas aeruginosa in the lungs for over a decade. It is approved for people aged 6 and over with a lung function within a certain range.
Using TOBI as part of a regular treatment regimen can: